Moving Cell And Gene Therapies Into Chronic Conditions Depends On Durability, Safety

Technologies, Trials Designed For Long-Term Efficacy, Safety

 
• By Mandy Jackson
  
DATA_Puzzle Piece_186976547_1200.jpg
Safety and durability data are a key piece of the puzzle for cell and gene therapies in chronic diseases
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Gene Therapies

More from Advanced Therapies